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Previous studies demonstrated that treatment with su-
peroxide dismutase, a scavenger of superoxide anions,
limits the extent of myocardial injury in a canine prep-
aration of regional myocardial ischemia and reperfusion.
Little is known, however, about the effects of superoxide
dismutase on the healing of a myocardial infarct. There-
fore, this study was performed to determine whether
treatment with superoxide dismutase during myocardial
ischemia impairs formation of scar tissue after infarc-
tion. Dogs received 2 hour infusions of superoxide dis-
mutase or albumin (controls) by way of the left atrium
beginning ]5 minutes before and ending ]5 minutes after
a 90 minute occlusion of the left circumflex coronary
artery. Six weeks later the animals were killed.
Two-dimensional echocardiography was performed
There is accumulating evidence that superoxide anions and
other activated oxygen species are mediators of tissue injury
during reperfusion after myocardial ischemia (1,2). The nat-
ural defenses against oxygen-induced injury include super-
oxide dismutase, a ubiquitous enzyme that catalyzes the
dismutation of superoxide anions (3). Treatment with su-
peroxide dismutase reduces myocardial damage in experi-
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before surgery and before induced death. Wall thick-
ening in the central ischemic zone was decreased at 6
weeks compared with baseline studies (p < 0,05), but
the decrease was similar for both groups. The hydrox-
yproline concentrations (p.g/mg dry weight) of the scar
tissue in the superoxide dismutase and control groups,
respectively, were 35.3 ± 3.8 and 28.7 ± 5.0 (p < 0.05).
The ratios of the scar thickness to normal wall thickness
were superoxide dismutase 0.9] ± 0.03 and control 0.89
± 0.03 (p > 0.05). Thus, superoxide dismutase had no
adverse effect on wall thickening or scar formation as-
sessed 6 weeks after myocardial infarction, and may be
useful to limit oxygen radical-mediated damage during
reperfusion of the ischemic myocardium.
(J Am Coil Cardiol 1987;9:898-902)
mental preparations of in vivo regional myocardial ischemia
followed by reperfusion (4,5) .
By virtue of the proinflammatory actions of superoxide
anions, superoxide dismutase exhibits anti-inflammatory
properties in a variety of experimental preparations of tissue
injury (3). Other agents that exert anti-inflammatory actions,
such as ibuprofen (6,7), indomethacin (8,9) and methyl-
prednisolone ( 10- 13), manifest deleterious effects on infarct
healing , resulting in infarct expansion and scar thinning.
Therefore, this study was performed to evaluate the effect
of treatment with superoxide dismutase during acute myo-
cardial ischemia on myocardial healing in a canine prepa-
ration of myocardial infarction .
Methods
Experimental preparation. Thirty-one male mongrel
dogs ( 12 to 17kg) free of circulat ing filariae were anesthe -
tized with sodium pentobarbital (30 rug/kg body weight ,
intravenously) and ventilated with room air. The lead II
electrocardiogram (ECG) was monitored. Using an aseptic
technique, a left thoracotomy was performed. The left atrial
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appendage was cannulated for adm inistration of drug in-
fusions. The proximal left circumflex coronary artery was
isolated and instrumented with an electromagnetic flow probe.
After measurement of basal coronary blood flow, the left
circumflex co ronary artery was constricted with a silk lig-
ature tied around the vessel and an 18 or 19 gauge needle .
The degree of a partial constriction was adjusted to reduce
by at least 50% the hyperem ic response to a 10 second
occl usion without altering basal flow. This stenosis is de-
signed to curtai l reperfusion arrhythmias and hemorrhagic
infarction by limit ing reperfu sion hyperem ia (14).
Experimental protocol. Animals were randomized to
receiv e either bovine liver superoxide dismutase , 5 mg/kg
(3,800 Uzmg. Diagnostic Data, Inc.), or bovine serum al-
bumin fraction V, 15 mg/kg (Calbiochem), dissolved in 60
ml of sterile 0 .9% sodium chloride . Albumin was selected
as a nonspecific protein contro l for any osmotic effects of
the enzyme . The solutions were infused by way of the left
atr ium at 0.5 ml/min for 2 hours beginning 15 minutes
before and ending 15 minut es after a 90 minute occlu sion
of the left circumflex coronary artery . Refle w through the
left circumflex coronary artery was increased gradually over
30 minutes by slowly releasing the Sila stic occluder. After
reflow for 30 minutes, the occluder, flow probe, stenosis
and left atr ial cannula were removed . The thoracotomy was
clo sed and the animals were allowed to recover from anes-
thesia.
All animals received preoperative and postoperative an-
tibiot ic prophylaxis . Four to six weeks after surgery the
animals were anesthetized with Dial-u rethane (0 .6 ml/kg ,
intravenously) , and the heart was then electrically fibril-
lated .
Two-dimensional echocardiographic stud ies. Two-di-
mensional echocardiograms were performed with the anim al
in the right lateral decubitus position on a specially con-
structed table with a cutout allowing transducer positioning
below the right lateral precordium. Using a Diason ics CRC
minicomputer-based video digitizing sys tem, end-diastolic
and end -systolic frames were selected for analysis. End-
diastole was defined by the onset of the Q wave in lead II
and end- systole was defined by the nadir of ventricular cav-
ity size . The endocardia l and epicardial borde rs of three
consec utive beats were traced directly from the video display
of short-axis images at the level of the midpap illary muscle .
Each frame was analyzed using a program that determines
a diastolic center of mass and ca lculates regional wall thick-
ness for 16 22 .5° radial segments (15) . Rotation was cor -
rected by fixing 1350 at the midpoint of the posterior pap-
illary muscle. Wall thickening was calculated as (end-systolic
wall thickness - end-diastolic wall thickness)/end-di astolic
wall thickness X 100%. Echocardiogram s were performed
before surgery and befo re induced death with the animals
awake or lightl y sedated with a benzodiazep ine deri vative .
Assessment of wall thickness. The heart was excised
and cut into I em thick transverse sections. The outline of
the left ventricle and infarct scar were traced onto clear
acetate sheets . Sampl es of the infarct scar and opposi te
ventricular wall were frozen for subsequent determination
of the hydroxyproline concentration.
The thicknesses of the scar and norm al left ventricle were
assessed by the method of Brown et al. (6). For each trans-
verse section, a ratio of scar thickness to noninfarcted left
ventricle was obtained by measurin g the thickne ss of the
normal left ventricle and scar in several locations. For each
heart , the average scar ratio was calculated from the ratios
of each section containing scar.
Measurement of hydroxyproline concentration. Tis-
sue samples for hydroxyprol ine concentration were homog-
enized in 2 ml of 0.5 M acetic acid, dried overnight and
hydrolyzed with 2 ml of hydrochloric ac id . After heatin g
at 120De ove rnight, the spec imens were centrifuged at 2,500
rpm for 10 minutes and dried . The dried sample was dis-
solved in 0 .5 ml of pH 6 buffer for analysis of the hydrox-
yproline concentrati on by the method of Huszar et al. (16) .
Hydroxyproline concentration was expressed as microgram s
per gram of dry tissue .
Histology, Sampl es of the infarct scars were also fixed
in 10% neutral formalin for histopathologic evaluation. Par-
affin-embedded tissue s were cut into 5 /Lm thick sections
and stained with hemat oxylin-eosin . Sl ides were evaluated
by an investigator (G .D .A.) who had no knowled ge of the
treatment received in any case .
Statistics . All data are expressed as mean ::!:: SE M.
Differences were conside red sig nificant whe n probability
(p) < 0.05 . The ratios of scar to non infarcted wall thickness
and the tissue hydro xyproline concentrations of the super-
oxide dismutase and contro l groups were compared using
an unpaired ( test. Paired ( tests were used to compare the
tissue hydroxyproline concentrations of the normal and scar
tissue within each group. Fisher's exact test was used to
compare the survival of the two group s of animals.
Results
Treatment groups. The study grou p consisted of 3 1
dogs . Four were prospect ively exclud ed for failure to de-
velop ST segment elevation after coron ary occlusion (three
control s, one receiving superoxide dismutase), Eight ani-
mals received countershocks to treat ventricular fibrillation.
Three died of intractable ventricular fibrillation dur ing coro-
nary occlu sion (two controls, one receiving superoxide dis-
mutase). Defibrillation was unsuccessful in one control dog
that developed ventricular fibrillati on 30 minute s after re-
perfu sion . One dog treated with superoxi de dismutase was
defibrill ated successfully dur ing coronary occlusion but died
several hours after surgery . The remaining three dogs with
ventricular fibrillation (two controls , one receiving super-
oxide dismutase) surviv ed for 6 week s. Although overall
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Table l. Effects on Wall Thickening in Ischemic and
Nonischemic Zones
long-term survival was better for the superoxide dismutase
group (8 of 10) than for the control group (7 of 17), the
difference was not statistically significant (p = 0.058).
Two-dimensional echocardiographic studies (Table 1).
Echocardiographic data from seven superoxide dismutase-
treated and four control dogs were available for analysis.
After infarction, the ratios of end-diastolic thickness of the
central-ischemic and nonischemic left ventricle were 1.04
± 0.03 for the control group and 1.02 ± 0.02 for the
superoxide dismutase group (p > 0.05). Wall thickening in
the central ischemic region was significantlydecreased after
infarction compared with baseline for both the superoxide
dismutase and control groups. The baseline and postinfarc-
tion wall thickening of the control and superoxide dismutase
groups were not significantly different.
Measurement of scar thickness and hydroxyproline.
The mean ratios of scar thickness to normal wall thickness
were 0.91 ± 0.03 for the superoxide dismutase treatment
group and 0.89 ± 0.03 for the control group, which are
not significantly different (p > 0.05; Fig. I). The hydrox-
yproline concentration in the scar tissue was approximately
10-fold greater than the concentration in the noninfarcted
tissue (p < 0.01; Fig. 2). Although there was a trend toward
greater hydroxyproline concentrations in both the normal
and the infarct specimens in the superoxidedismutase group,
the differences were not statistically significant when com-
pared with findings in the control group (p > 0.05).
Histology. In the control dogs, the infarctedmyocardium
was found to have been replaced by dense, collagenousscars
with scattered clusters of macrophages containing either
debris or hemosiderin, along with lesser numbers of lym-
phocytes and plasma cells. No islands of necrotic tissue
remained, and virtually no neutrophils were present. In ap-
proximately half of the animals, foci of dystrophic calcifi-
cation were scattered in the scar, and amid the basophilic
deposits in these foci were occasional fragments of what
appeared to be calcium-encrusted, necrotic myocardial fi-
bers. The qualitative histologic appearance of the hearts
from the superoxide dismutase group was similar in all
respects to that of the control group. The range of density,
cellularity and vascularity of the scars was the same in both
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Figure 2. Hydroxyproline concentrations of scarand normal left
ventricle of seven control animals and seven animals treated with
superoxide dismutase (SOD). Forboth groups, thehydroxyproline
concentration of the scar tissue was significantly greater than that
of the normal left ventricle (p < 0.01). There were no significant
differences in either zone between thecontrol and superoxide dis-
mutase groups.
Discussion
Drugeffects on infarct healing. Oxygen radicals have
proinflammatory actions, including generation of chemo-
tactic factors by reaction with plasma lipids, and inactivation
of serum inhibitors of leukocytic proteases (3). Conse-
quently, superoxide dismutase and some other scavengers
of free radicals can inhibit the inflammatory response to
tissue injury (3). Drugs possessing anti-inflammatory prop-
erties, such as glucocorticoids and nonsteroidal anti-inflam-
matory agents, may have long-term deleterious effects on
infarct healing that outweigh their short-term benefits on
infarct size. For example, similar schedules of ibuprofen
were associated with a 40% reduction in acute myocardial
injury (17) and thinning of the left ventricular scar 6 weeks
Figure I. Ratios of scar thickness to normal wall thickness of
seven control animals and eight animals treated with superoxide
dismutase (SOD). The groups are not significantly different (p <
0.05). Bars represent the mean of each group. LV = left ven-
tricular.
groups. The cellular infiltrate and the scattered foci of dys-
trophic calcification were likewise indistinguishable.
63.6 ± 4.7
40.9 ± 3.5*
66.2 ± 4.6
90.8 ± 11.6
Superoxide Dismutase
(%)
Control
(%)
69.7 ± 4.3
75.3 ± 9.9
59.0 ± 6.0
37.2 ± 7.2*
*p < 0.05 versus baseline.
Ischemic zone
Baseline
Postinfarction
Nonischemic zone
Baseline
Postinfarction
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after infarction (6). Methylprednisolone was also shown to
cause both reduction of infarct size and thinning of the
previously infarcted myocardial region (I I). Treatment with
superoxide dismutase, at a dose previously shown to reduce
acute myocardial injury by 50% (4), did not cause thinning
of infarcted myocardium in this study. The ratios of scar
thickness to normal wall thickness for both the control group
(0.89) and the superoxide dismutase group (0.9 1)are similar
to the control ratios of 0.87 and 0.88 published by another
group of investigators (6, 12).
Pathogenesis of infarct thinning. The effects of phar-
macologic interventions on ultimate scar formation after
myocardial infarction cannot be predicted with certainty.
Recently , it was reported that treatment with methylpred-
nisolone caused a reduction in scar thickness in experimental
myocardial infarction in rats. The effect was associated with
a reduction in early mononuclear cell infiltration (13). Ibu-
profen also was shown to suppress leukocyte infiltration of
reperfused ischemic canine myocardium (17). Although one
might infer that the mechanism of drug-induced scar thin-
ning relates to inhibition of inflammatory cell invasion, other
data are inconsistent with this line of reasoning. Indometh-
acin was shown to cause infarct thinning (8), but the drug
increases leukocyte migration at low doses (18) and only
weakly inhibits the migration of leukocytes at higher doses
(19). Prostacyclin inhibits neutrophil stimulation (20). but
does not result in scar thinning (7). Similarly, superoxide
dismutase was reported (21) to inhibit leukotriene B4-in-
duced leukocyte chemotaxis, and no evidence of scar thin-
ning was apparent in this study.
Pharmacologic effects on infarct scar for mation appear
to be independent of effects on infarct size. Indomethacin
(9) and methylprednisolone (22) were reported to cause
thinning of infarcts in the absence of changes in infarct size.
Infarct expansion was also demonstrated in dogs treated with
indomethacin (9) and methylprednisolone (22). Infarct ex-
pansion, however, does not correlate closely with the extent
of infarction (23). Thus, the effects of drugs on infarct
expansion and thinning may be unrelated to effects on the
extent of acute injury . Further work is required to elucidate
the mechanisms of drug-induced infarct expansion and thin-
ning.
Recovery of function. The role of oxygen free radicals
in postischemic ventricular dysfunction, that is, myocardial
stunning, is currently an area of active investigation. Three
recent studies (24-26) concluded that treatment with su-
peroxide dismutase and catalase enhances the recovery of
myocardial function in dogs subjected to coronary occlusion
for 15 minutes followed by reperfusion for 2 (24) or 3 hours
(25,26). Several factors may underlie the failure of our study
to detect a functional difference between the superoxide
dismutase and control groups. First, mortality was 20% for
the superoxide dismutase group and 60% for the control
group. Thus, control animals with a large infarct and poor
left ventricular function may have died prematurely. thereby
obscuring any beneficial effects of superoxide dismutase on
left ventricular function. Second, as demonstrated in this
study, there is significant resolution of regional dysfunction
in a canine preparation of chronic myocardial infarction
(27), probably as a result of epicardial functional remodeling
and changes in left ventricular topography. Reimer and Jen-
nings (28) found that between 4 and 28 days after canine
myocardial infarction, the mean infarct area decreased from
4 1 to I 1% of the left ventricle, whereas the nonischemic
myocardium hypertrophied. Comparing canine infarcts after
2 days and 6 weeks, Jugdutt and Amy (29) observed a 60%
decrease of infarct area and 28% increase of the endocardial
length of the noninfarcted left ventricle. The temporal changes
described would complicate efforts to relate the area of scar
and extent of contractile dysfunction to two major deter-
minants of acute ischemic injury, the area at risk of infarc-
tion and the collateral blood fl ow (28). Consequently, an-
atomic assessment of scar area and functional measurement
of myocardial contraction 6 weeks after acute myocardial
injury may have limited sensitivity for differences that ex-
isted early after the ischemic event.
Conclusions. As discussed recently by BraunwaId and
Kloner (30). reperfusion has both beneficial and detrimental
effects on ischemic myocardium. Agents administered to
counter the detrimental effects of reperfusion, however, might
increase morbidity and mortality by promoting scar thinning
and formation of a left ventricular aneurysm (31). The re-
sults of this study indicate that treatment with superoxide
dismutase during myocardial ischemia has no qualitative or
quantitative effects on myocardial scar formation. Thus,
superoxide disrnutase, and possibly other agents that scav-
enge oxygen radicals, might be administered before reper-
fusion without adversely affecting the processes associated
with healing of myocardium injured by ischemia.
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